Related Experiment Video
Updated: Mar 10, 2026

08:51
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
Published on: March 15, 2019
13.1K
Antibody repertoire profiling with mimotope arrays
Shina Pashova1, Christoph Schneider2, Stephan von Gunten2
1a Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences , Sofia , Bulgaria.
Human Vaccines & Immunotherapeutics
|December 9, 2016
Summary
Antibody repertoire profiling using next-generation sequencing and other methods maps antibody reactivities to structures. This analysis aids in understanding antibody specificities for disease prediction and vaccine development.
Area of Science:
- Immunology
- Biotechnology
- Bioinformatics
Background:
- Antibody repertoires are crucial for adaptive immunity and disease response.
- Understanding antibody reactivity is key for diagnostics and therapeutics.
- Current profiling methods offer insights but have limitations.
Purpose of the Study:
- To review major antibody repertoire profiling techniques.
- To discuss the application of these techniques in disease prediction and vaccination.
- To evaluate the advantages and disadvantages of current methods.
Main Methods:
- Next-generation sequencing (NGS) for large-scale antibody profiling.
- Phage display libraries for identifying antibody-binding targets.
- Microarrays for analyzing antibody reactivities against structured arrays (peptides, carbohydrates).
Main Results:
- Profiling techniques enable mapping of antibody reactivities to specific structures, termed mimotopes.
- These methods can analyze individual antibody specificities or complex binding patterns.
- The study discusses the strengths and weaknesses of each profiling approach.
Conclusions:
- Antibody repertoire profiling is essential for advancing disease prediction and vaccine design.
- Combining techniques like NGS, phage display, and microarrays offers a powerful pipeline.
- Further development is needed to fully leverage these methods for clinical applications.

